tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 1153 are a BUY (92.91%), 84 are a HOLD (6.77%), 4 are a SELL (0.32%).
Analyst Raghuram Selvaraju, carries an average stock price target met ratio of 35.36% that have a potential upside of 54.98% achieved within 194 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 2,259 price targets and ratings displayed on 130 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on ACRS, Aclaris Therapeutics at 21-Jan-2026.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 12-May-2021
$12
$-4.26 (-26.20%)
$7
7 months 1 days ago
(25-Jun-2025)
8/13 (61.54%)
$-4.19 (-25.88%)
55
Buy Since 16-Apr-2021
1 years 7 months 8 days ago
(18-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell Since 06-May-2022
2 years 2 months 6 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold Since 25-Oct-2023
$20
$3.74 (23.00%)
$60
2 years 3 months 1 days ago
(25-Oct-2023)
3/22 (13.64%)
$5.8 (40.85%)
40
Hold Since 04-May-2022
$25
$8.74 (53.75%)
$40
2 years 6 months 7 days ago
(19-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
